RMD Stock Overview
Develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 2/6 |
| Past Performance | 6/6 |
| Financial Health | 6/6 |
| Dividends | 4/6 |
Rewards
Risk Analysis
No risks detected for RMD from our risk checks.
Community Narratives
Create a narrativeNarratives bring a range of perspectives from our community.
ResMed Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$241.55 |
| 52 Week High | US$260.49 |
| 52 Week Low | US$151.95 |
| Beta | 0.69 |
| 11 Month Change | 0.62% |
| 3 Month Change | 8.12% |
| 1 Year Change | 58.28% |
| 33 Year Change | -5.27% |
| 5 Year Change | 60.15% |
| Change since IPO | 35,851.63% |
Recent News & Updates
Shareholders May Not Be So Generous With ResMed Inc.'s (NYSE:RMD) CEO Compensation And Here's Why
Nov 13
We Think ResMed (NYSE:RMD) Can Manage Its Debt With Ease
Nov 01Recent updates
Shareholders May Not Be So Generous With ResMed Inc.'s (NYSE:RMD) CEO Compensation And Here's Why
Nov 13We Think ResMed (NYSE:RMD) Can Manage Its Debt With Ease
Nov 01Here's Why We Think ResMed (NYSE:RMD) Might Deserve Your Attention Today
Oct 20ResMed Inc.'s (NYSE:RMD) Intrinsic Value Is Potentially 47% Above Its Share Price
Oct 08Why ResMed's Rally Is Just Getting Started
Sep 18ResMed Inc.'s (NYSE:RMD) Earnings Haven't Escaped The Attention Of Investors
Sep 13ResMed (NYSE:RMD) Is Increasing Its Dividend To $0.53
Aug 05Does ResMed (NYSE:RMD) Have A Healthy Balance Sheet?
Jul 29Returns On Capital Are A Standout For ResMed (NYSE:RMD)
Jul 15ResMed: Asymmetrical Value Opportunity With High Prospect Of Re-Rating
Jul 03An Intrinsic Calculation For ResMed Inc. (NYSE:RMD) Suggests It's 33% Undervalued
Jul 02ResMed (NYSE:RMD) Seems To Use Debt Quite Sensibly
Apr 30Earnings Beat: ResMed Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
Apr 30ResMed Inc.'s (NYSE:RMD) Popularity With Investors Is Clear
Apr 18With EPS Growth And More, ResMed (NYSE:RMD) Makes An Interesting Case
Mar 22Capital Investments At ResMed (NYSE:RMD) Point To A Promising Future
Mar 10An Intrinsic Calculation For ResMed Inc. (NYSE:RMD) Suggests It's 30% Undervalued
Feb 12Why ResMed Is One Of My Top Picks In 2024
Jan 22A First Look At ResMed
Jan 09ResMed Inc.'s (NYSE:RMD) Share Price Could Signal Some Risk
Dec 20Why You Should Care About ResMed's (NYSE:RMD) Strong Returns On Capital
Dec 06Shareholders May Find It Hard To Justify Increasing ResMed Inc.'s (NYSE:RMD) CEO Compensation For Now
Nov 10Are Investors Undervaluing ResMed Inc. (NYSE:RMD) By 41%?
Nov 01ResMed: Weight-Loss Drug Worries Provide Buying Opportunity
Oct 28ResMed: Stock Re-Rating To 20x Forward P/E Is A Buy Opportunity
Sep 12ResMed Has Become A Steal (Rating Upgrade)
Aug 10ResMed's (NYSE:RMD) Shareholders Will Receive A Bigger Dividend Than Last Year
Aug 07ResMed (NYSE:RMD) Has Some Way To Go To Become A Multi-Bagger
Jul 30Here's Why We Think ResMed (NYSE:RMD) Might Deserve Your Attention Today
Jul 16Compound Your Wealth With ResMed
Jul 04A Look At The Fair Value Of ResMed Inc. (NYSE:RMD)
Jul 02We Think ResMed (NYSE:RMD) Can Stay On Top Of Its Debt
May 26Shareholder Returns
| RMD | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | 2.6% | -0.8% | -1.2% |
| 1Y | 58.3% | 20.9% | 30.4% |
Return vs Industry: RMD exceeded the US Medical Equipment industry which returned 20.9% over the past year.
Return vs Market: RMD exceeded the US Market which returned 30.4% over the past year.
Price Volatility
| RMD volatility | |
|---|---|
| RMD Average Weekly Movement | 4.3% |
| Medical Equipment Industry Average Movement | 7.9% |
| Market Average Movement | 6.2% |
| 10% most volatile stocks in US Market | 15.5% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: RMD has not had significant price volatility in the past 3 months compared to the US market.
Volatility Over Time: RMD's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1989 | 9,980 | Mick Farrell | www.resmed.com |
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; and NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry over several nights.
ResMed Inc. Fundamentals Summary
| RMD fundamental statistics | |
|---|---|
| Market cap | US$34.94b |
| Earnings (TTM) | US$1.11b |
| Revenue (TTM) | US$4.81b |
31.9x
P/E Ratio7.4x
P/S RatioIs RMD overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| RMD income statement (TTM) | |
|---|---|
| Revenue | US$4.81b |
| Cost of Revenue | US$2.00b |
| Gross Profit | US$2.80b |
| Other Expenses | US$1.69b |
| Earnings | US$1.11b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 7.58 |
| Gross Margin | 58.33% |
| Net Profit Margin | 23.15% |
| Debt/Equity Ratio | 13.0% |
How did RMD perform over the long term?
See historical performance and comparisonDividends
0.9%
Current Dividend Yield26%
Payout RatioDoes RMD pay a reliable dividends?
See RMD dividend history and benchmarks| ResMed dividend dates | |
|---|---|
| Ex Dividend Date | Nov 07 2024 |
| Dividend Pay Date | Dec 12 2024 |
| Days until Ex dividend | 14 days |
| Days until Dividend pay date | 21 days |
Does RMD pay a reliable dividends?
See RMD dividend history and benchmarks